Chan A - Search Results

1

Role of Exosomes in Cancer-Related Cognitive Impairment.

Koh YQ, Tan CJ, Toh YL, Sze SK, Ho HK, Limoli CL, Chan A. Koh YQ, et al. Among authors: chan a. Int J Mol Sci. 2020 Apr 15;21(8):2755. doi: 10.3390/ijms21082755. Int J Mol Sci. 2020. PMID: 32326653 Free PMC article. Review.

2

Neuro-cognitive impairment in breast cancer patients: pharmacological considerations.

Cheung YT, Chui WK, Chan A. Cheung YT, et al. Among authors: chan a. Crit Rev Oncol Hematol. 2012 Jul;83(1):99-111. doi: 10.1016/j.critrevonc.2011.09.001. Epub 2011 Oct 19. Crit Rev Oncol Hematol. 2012. PMID: 22015329 Review.

3

Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence.

Teo YL, Saetaew M, Chanthawong S, Yap YS, Chan EC, Ho HK, Chan A. Teo YL, et al. Among authors: chan a, chan ec. Breast Cancer Res Treat. 2012 Jun;133(2):703-11. doi: 10.1007/s10549-012-1995-7. Epub 2012 Feb 28. Breast Cancer Res Treat. 2012. PMID: 22370628

4

Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: a meta-analysis.

Teo YL, Ho HK, Chan A. Teo YL, et al. Among authors: chan a. Cancer Treat Rev. 2013 Apr;39(2):199-206. doi: 10.1016/j.ctrv.2012.09.004. Epub 2012 Oct 23. Cancer Treat Rev. 2013. PMID: 23099278

5

Vascular endothelial growth factor inhibitors and cognitive impairment: evidence and controversies.

Ng T, Cheung YT, Ng QS, Ho HK, Chan A. Ng T, et al. Among authors: chan a. Expert Opin Drug Saf. 2014 Jan;13(1):83-92. doi: 10.1517/14740338.2013.828034. Epub 2013 Aug 12. Expert Opin Drug Saf. 2014. PMID: 23931162 Review.

6

Role of sunitinib and SU12662 on dermatological toxicities in metastatic renal cell carcinoma patients: in vitro, in vivo, and outcomes investigation.

Teo YL, Chong XJ, Chue XP, Chau NM, Tan MH, Kanesvaran R, Wee HL, Ho HK, Chan A. Teo YL, et al. Among authors: chan a. Cancer Chemother Pharmacol. 2014 Feb;73(2):381-8. doi: 10.1007/s00280-013-2360-1. Epub 2013 Dec 4. Cancer Chemother Pharmacol. 2014. PMID: 24306119

7

Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research.

Cheung YT, Lim SR, Ho HK, Chan A. Cheung YT, et al. Among authors: chan a. PLoS One. 2013 Dec 5;8(12):e81234. doi: 10.1371/journal.pone.0081234. eCollection 2013. PLoS One. 2013. PMID: 24339912 Free PMC article. Review.

8

Teo YL, Ho HK, Chan A. Teo YL, et al. Among authors: chan a. Br J Clin Pharmacol. 2015 Feb;79(2):241-53. doi: 10.1111/bcp.12496. Br J Clin Pharmacol. 2015. PMID: 25125025 Free PMC article. Review.

9

Formation of reactive metabolites and management of tyrosine kinase inhibitor-induced hepatotoxicity: a literature review.

Teo YL, Ho HK, Chan A. Teo YL, et al. Among authors: chan a. Expert Opin Drug Metab Toxicol. 2015 Feb;11(2):231-42. doi: 10.1517/17425255.2015.983075. Epub 2014 Nov 15. Expert Opin Drug Metab Toxicol. 2015. PMID: 25400226 Review.

10

The genetic variants underlying breast cancer treatment-induced chronic and late toxicities: a systematic review.

Ng T, Chan M, Khor CC, Ho HK, Chan A. Ng T, et al. Among authors: chan a, chan m. Cancer Treat Rev. 2014 Dec;40(10):1199-214. doi: 10.1016/j.ctrv.2014.10.001. Epub 2014 Oct 14. Cancer Treat Rev. 2014. PMID: 25458605

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,112 results

Search Page